
Sign up to save your podcasts
Or


🧠✨ New Stroke Breakthrough!
The ASSET-IT trial shows that early infusion of tirofiban after thrombolysis significantly boosts recovery in noncardioembolic stroke patients — with 65.9% achieving excellent outcomes at 90 days vs 54.9% with placebo 📈💉
✅ Improved function
⚠️ Slightly higher bleeding risk
🌏 Study conducted across 38 centers in China
📚 Read the trial in NEJM (July 2025)
#Stroke #Tirofiban #Neurology #RCT #PrecisionMedicine #Thrombolysis #CardiovascularResearch
By Dr RR Baliga, MD, MBA5
66 ratings
🧠✨ New Stroke Breakthrough!
The ASSET-IT trial shows that early infusion of tirofiban after thrombolysis significantly boosts recovery in noncardioembolic stroke patients — with 65.9% achieving excellent outcomes at 90 days vs 54.9% with placebo 📈💉
✅ Improved function
⚠️ Slightly higher bleeding risk
🌏 Study conducted across 38 centers in China
📚 Read the trial in NEJM (July 2025)
#Stroke #Tirofiban #Neurology #RCT #PrecisionMedicine #Thrombolysis #CardiovascularResearch

893 Listeners

3,374 Listeners

21,477 Listeners